2012
DOI: 10.1093/icvts/ivs243
|View full text |Cite
|
Sign up to set email alerts
|

The use of lanreotide in the management of lymphorrhea after an aortic valve replacement

Abstract: Lymphorrhea is a rare but potentially serious complication following various surgical procedures. Uncontrolled lymph drainage may lead to infection and prolonged hospital stay. Currently, there is no standard effective treatment. Early management usually involves bed rest, drainage and pressure dressings. These methods are associated with prolonged recovery and high recurrence rates. We report a case of lymphorrhea from the groin wound after an aortic valve replacement. The patient presented with significant l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 5 publications
0
5
0
Order By: Relevance
“…In our case, the drainage was external and moderate, neither causing hypoproteinemia nor interfering with wound healing or causing infection, which are complications caused by lymphorrhea. 15 In addition, lymphoscintigraphy showed no disrupted lymphatic vessels, probably since it was done after the prolonged compression, which proved to be very effective in our case, and consequently more invasive therapy was not indicated.…”
Section: Discussionmentioning
confidence: 56%
“…In our case, the drainage was external and moderate, neither causing hypoproteinemia nor interfering with wound healing or causing infection, which are complications caused by lymphorrhea. 15 In addition, lymphoscintigraphy showed no disrupted lymphatic vessels, probably since it was done after the prolonged compression, which proved to be very effective in our case, and consequently more invasive therapy was not indicated.…”
Section: Discussionmentioning
confidence: 56%
“…In extreme cases, when the lymphatic leak reached 500 ml/day, parenteral nutrition was stopped and intravenous supplementation was administered instead. In selected cases, a dose of 3.5 µg/kg b.w./h of somatostatin IV was administered by means of an infusion pump [ 5 , 6 , 18 ]. The somatostatin infusion was maintained for 72 h on average.…”
Section: Discussionmentioning
confidence: 99%
“…Somatostatin is a tetrapeptide hormone found among the nervous and the gastroenteropancreatic system. A direct effect of somatostatin on the lymph flow has only been observed in the gastrointestinal track; nevertheless, somatostatin receptors have been found in lymphatic tissues, within and outside of the gastrointestinal track [ 3 ]. Other treatments include instillation of doxycycline as a sclerosing agent into the lymphatic vessels [ 4 ].…”
Section: Discussionmentioning
confidence: 99%